KH7是可溶性腺苷酸环化酶(sAC)的特异性抑制剂,在细胞中对重组sACt蛋白(人类和其他物种)的IC50为3-10 μM。KH7也是cAMP的抑制剂。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Soluble adenylate cyclase (sAC) is a non-plasma membrane bound form of adenylate cyclase (AC) that produces the second messenger adenosine 3’,5’-cyclic AMP (cAMP) from ATP. It has been suggested to be involved in various cellular and physiological processes. KH 7, working as a classical uncoupler, is a sAC-specific inhibitor with an IC50 of 2.7 μM. KH 7 at 25 μM inhibited ATP production by reducing respiration at lower concentrations and by perturbing membrane potential at higher concentrations in isolated mouse liver mitochondria[2]. Application of the KH 7 showed almost complete inhibition of ATP-induced [Ca2+]i elevation in pretreated EA.hy926 cells indicating it reduces intracellular Ca2+ response[3]. In vivo, KH 7 (1.25 mM dissolved in 4 mL/kg DMSO) treatment caused an increased IOP (intraocular pressure) in avertin- and KXA(ketamine/xylazine/acepromazine)-anesthetized C57BL/6J mice compared with DMSO controls. In mice, KH 7 (5 μM) decreased outflow facility by 85.1% in nonanesthetized, enucleated eyes[4]. |
| Concentration | Treated Time | Description | References | |
| NHBE cells | 50 μM | To test the inhibitory effect of KH7 on sAC activity | Am J Respir Cell Mol Biol. 2014 Dec;51(6):750-60. | |
| Islet β-cells | 30 μmol/L | KH7 inhibited glucose-induced [cAMP]pm oscillations | Diabetes. 2011 May;60(5):1535-43. | |
| MIN6 β-cells | 30 μmol/L | KH7 inhibited glucose-induced [cAMP]pm oscillations | Diabetes. 2011 May;60(5):1535-43. | |
| PBMCs | 25 μM | 30 minutes | Minimal effect on basal cAMP levels | J Nutr Biochem. 2011 Jul;22(7):681-90. |
| HEK293T cells | 50 μM | 48 hours | To test the inhibitory effect of KH7 on sAC activity | Am J Respir Cell Mol Biol. 2014 Dec;51(6):750-60. |
| Primary mouse cholangiocytes | 100 μM | 3 hours | KH7 treatment also prevented NaGCDC-induced apoptosis in primary mouse cholangiocytes. | Hepatology. 2016 Aug;64(2):522-34. |
| H69 human cholangiocytes | 50-100 μM | 1 hour | KH7 dose-dependently inhibited BSIA in both control and AE2 knockdown cholangiocytes and at higher concentrations also prevented NaCDC-induced apoptosis altogether. | Hepatology. 2016 Aug;64(2):522-34. |
| HEK293 cells | 50 μM | KH7 inhibited the pH recovery rate in sAC-overexpressing HEK293 cells | Invest Ophthalmol Vis Sci. 2014 Jan 9;55(1):187-97. | |
| Nonpigmented ciliary epithelial cells (NPE) | 50 μM | 2 minutes | KH7 significantly reduced the acetazolamide-induced increase in cAMP | Invest Ophthalmol Vis Sci. 2014 Jan 9;55(1):187-97. |
| MLTC-1 cells | 6.25, 12.5, 50, 100 µM | 1 hour | KH7 dose-dependently inhibited LH-stimulated cAMP accumulation, with 100 µM concentration almost completely abolishing cAMP accumulation | Int J Mol Sci. 2021 Apr 28;22(9):4641. |
| Cardiac fibers | 5 μM | 30 minutes | KH7, a soluble adenylyl cyclase inhibitor, reduced ADP-stimulated respiratory rates | Int J Mol Sci. 2016 Dec 10;17(12):2075. |
| PBMCs | 10 or 25 μM | 30 minutes | Inhibition of sAC activity, reduction in cAMP levels | J Nutr Biochem. 2011 Jul;22(7):681-90. |
| Ciona intestinalis sperm | 10 μM | 3 min | Investigate the effect of KH-7 on sperm motility and trajectory, results showed KH-7 significantly reduced swimming velocity and decreased the diameter of sperm trajectory. | Int J Mol Sci. 2014 Jul 28;15(8):13192-208. |
| Human endometrial epithelial cell line (ISK) | 10 µM | 24 hours | KH-7, a selective inhibitor of soluble adenylyl cyclase (sAC), was used to investigate the effect of ENaC knockdown or Ca2+ chelation on CFTR upregulation. Results showed that KH-7 completely reversed the CFTR mRNA increase induced by low-degree ENaC knockdown or BAPTA-AM, suggesting the involvement of sAC-driven cAMP production in the regulation of CFTR. | Front Cell Dev Biol. 2022 Aug 30;10:781762. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | SAC C2KO mice | Perfusion | 25 μM | To test the regulatory effect of KH7 on CBF | Am J Respir Cell Mol Biol. 2014 Dec;51(6):750-60. | |
| Male DBA/1 J mice | Collagen-induced arthritis (CIA) mouse model | Intraperitoneal injection | 6 mg/kg | Three times a week for 6 weeks | To evaluate the inhibitory effect of KH7-33 mAb on arthritic symptoms. Results showed that KH7-33 mAb significantly ameliorated the arthritis index, squeaking index, and paw volume. | Arthritis Res Ther. 2018 Oct 30;20(1):245 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00035490 | Arrhythmia | Phase 3 | Completed | - | - |
| NCT03127059 | Dysfunctional Breathing in Ast... 展开 >>hma 收起 << | Not Applicable | Recruiting | November 2020 | Denmark ... 展开 >> Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Silkeborg, Central Denmark Region, Denmark, 8600 Contact: Karen H Andreasson khad@regionsjaelland.dk Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Bispebjerg, Danish Capital Region, Denmark Contact: Karen H Andreasson khad@regionsjaelland.dk Allergi og Lungeklinikken Helsingør Recruiting Helsingør, Danish Capital Region, Denmark, 3000 Contact: Karen H Andreasson khad@regionsjaelland.dk Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Hvidovre, Danish Capital Region, Denmark Contact: Karen H Andreasson khad@regionsjaelland.dk Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Aalborg, Region North, Denmark Contact: Karen H Andreasson khad@regionsjaelland.dk Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Naestved, Region Zealand, Denmark Contact: Karen H Andreasson, PT MSc +45 24 25 49 26 khad@regionsjaelland.dk Contact: Uffe Bødtger, MD PhD +45 56 51 45 92 ubt@regionsjaelland.dk Dep. of Physiotherapy and Dep. of Pulmonology Recruiting Roskilde, Region Zealand, Denmark Contact: Karen H Andreasson khad@regionsjaelland.dk 收起 << |
| NCT03616912 | Systemic Lupus Erythematosus | Phase 3 | Recruiting | February 16, 2021 | - |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.85mL 4.77mL 2.38mL |
|
| CAS号 | 330676-02-3 |
| 分子式 | C17H15BrN4O2S |
| 分子量 | 419.3 |
| SMILES Code | OC(C=CC(Br)=C2)=C2/C=N/NC(C(C)SC1=NC(C=CC=C3)=C3N1)=O |
| MDL No. | MFCD01230899 |
| 别名 | KH 7 free |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(596.24 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1